<?xml version="1.0" encoding="UTF-8"?>
<p>HEV-3 is native and widespread throughout Europe [
 <xref rid="pone.0225583.ref005" ref-type="bibr">5</xref>], including Croatia [
 <xref rid="pone.0225583.ref006" ref-type="bibr">6</xref>]. Active infections and high seroprevalence are measured on Croatian pig farms (up to 92%), in wild boar (up to 30%) as well as in humans (up to 15%) [
 <xref rid="pone.0225583.ref007" ref-type="bibr">7</xref>, 
 <xref rid="pone.0225583.ref008" ref-type="bibr">8</xref>, 
 <xref rid="pone.0225583.ref009" ref-type="bibr">9</xref>]. In contrast to other hepatitis viruses, experimental models other than nonhuman primates have been established, such as pigs, sheep and laboratory rats [
 <xref rid="pone.0225583.ref009" ref-type="bibr">9</xref>, 
 <xref rid="pone.0225583.ref010" ref-type="bibr">10</xref>]. Identification of anti-HEV antibodies in domestic animals like pigs, sheep and cattle [
 <xref rid="pone.0225583.ref011" ref-type="bibr">11</xref>], as well as the isolation and characterization of HEV isolates from domestic pigs similar to human HEV [
 <xref rid="pone.0225583.ref012" ref-type="bibr">12</xref>, 
 <xref rid="pone.0225583.ref013" ref-type="bibr">13</xref>] confirm that animals can be reservoirs for HEV.
</p>
